Desry Hyacinth
Acute Care · Orlando, FLNPI 1134849904
Payments from drug & device makers
Across 61 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$380
- Alnylam Pharmaceuticals Inc.$135
- Novartis$66
- Cvrx, Inc.$57
- Merck$55
- E.r. Squibb & Sons, L.L.C.$55
- plus $363 from 14 others
What the payments were for
- Food & beverage$1,111100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $380 |
| Alnylam Pharmaceuticals Inc. | 5 | $135 |
| Novartis | 3 | $66 |
| Cvrx, Inc. | 4 | $57 |
| Merck | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| United Therapeutics Corporation | 2 | $54 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $49 |
| Atricure, Inc. | 2 | $49 |
| Bayer | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Biosense Webster, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Medtronic | 1 | $13 |
How this compares
$1,111 in reported general payments places this provider in the 75th percentile of 1,150 acute care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 16 | $554,667 |
| EliquisApixaban | 61 | $73,728 |
| JardianceEmpagliflozin | 40 | $46,518 |
| EntrestoSacubitril/Valsartan | 29 | $36,884 |
| XareltoRivaroxaban | 20 | $33,451 |
| Repatha SureclickEvolocumab | 40 | $26,021 |
| BrilintaTicagrelor | 12 | $13,762 |
| FarxigaDapagliflozin Propanediol | 17 | $13,539 |
| Rosuvastatin Calcium | 52 | $1,068 |
| Nebivolol Hcl | 16 | $1,047 |
| Prasugrel Hcl | 11 | $714 |
| Metoprolol Succinate | 42 | $652 |
| Losartan Potassium | 72 | $595 |
| Carvedilol | 68 | $589 |
| Valsartan | 17 | $450 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $380 | $628,39577 claims |
| NovartisEntresto | $66 | $36,88429 claims |
| Johnson & JohnsonXarelto | $18 | $33,45120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,150 acute care providers in Florida.
Other acute care in Orlando
- Melisa WilsonOrlando$3.6M
- Ali SobhOrlando$15K
- Lamisa RaysideOrlando$7K
- Amanda PeacockJacksonville$81K
- Katrina RileyTampa$66K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melanie WeresJacksonville$37K
- Jayne JaramilloJacksonville$27K
- Melissa HamiltonTampa$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.